BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 28628103)

  • 1. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.
    Huang KL; Marcora E; Pimenova AA; Di Narzo AF; Kapoor M; Jin SC; Harari O; Bertelsen S; Fairfax BP; Czajkowski J; Chouraki V; Grenier-Boley B; Bellenguez C; Deming Y; McKenzie A; Raj T; Renton AE; Budde J; Smith A; Fitzpatrick A; Bis JC; DeStefano A; Adams HHH; Ikram MA; van der Lee S; Del-Aguila JL; Fernandez MV; Ibañez L; ; ; Sims R; Escott-Price V; Mayeux R; Haines JL; Farrer LA; Pericak-Vance MA; Lambert JC; van Duijn C; Launer L; Seshadri S; Williams J; Amouyel P; Schellenberg GD; Zhang B; Borecki I; Kauwe JSK; Cruchaga C; Hao K; Goate AM
    Nat Neurosci; 2017 Aug; 20(8):1052-1061. PubMed ID: 28628103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response.
    Pimenova AA; Herbinet M; Gupta I; Machlovi SI; Bowles KR; Marcora E; Goate AM
    Neurobiol Dis; 2021 Jan; 148():105217. PubMed ID: 33301878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer's disease.
    Jones RE; Andrews R; Holmans P; Hill M; Taylor PR
    Sci Rep; 2021 Jul; 11(1):14935. PubMed ID: 34294785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer's Disease Risk.
    Cao H; Zhou X; Chen Y; Ip FCF; Chen Y; Lai NCH; Lo RMN; Tong EPS; Mok VCT; Kwok TCY; ; Fu AKY; Ip NY
    J Alzheimers Dis; 2022; 86(4):1861-1873. PubMed ID: 35253752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a functional polymorphism in the 3'-untranslated region of SPI1 with systemic lupus erythematosus.
    Hikami K; Kawasaki A; Ito I; Koga M; Ito S; Hayashi T; Matsumoto I; Tsutsumi A; Kusaoi M; Takasaki Y; Hashimoto H; Arinami T; Sumida T; Tsuchiya N
    Arthritis Rheum; 2011 Mar; 63(3):755-63. PubMed ID: 21360505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks.
    Tansey KE; Cameron D; Hill MJ
    Genome Med; 2018 Feb; 10(1):14. PubMed ID: 29482603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.
    Karch CM; Ezerskiy LA; Bertelsen S; ; Goate AM
    PLoS One; 2016; 11(2):e0148717. PubMed ID: 26919393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PU.1 regulates Alzheimer's disease-associated genes in primary human microglia.
    Rustenhoven J; Smith AM; Smyth LC; Jansson D; Scotter EL; Swanson MEV; Aalderink M; Coppieters N; Narayan P; Handley R; Overall C; Park TIH; Schweder P; Heppner P; Curtis MA; Faull RLM; Dragunow M
    Mol Neurodegener; 2018 Aug; 13(1):44. PubMed ID: 30124174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease.
    Gjoneska E; Pfenning AR; Mathys H; Quon G; Kundaje A; Tsai LH; Kellis M
    Nature; 2015 Feb; 518(7539):365-9. PubMed ID: 25693568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating GWAS-Identified Risk Loci for Alzheimer's Disease in Han Chinese Populations.
    Wang HZ; Bi R; Hu QX; Xiang Q; Zhang C; Zhang DF; Zhang W; Ma X; Guo W; Deng W; Zhao L; Ni P; Li M; Fang Y; Li T; Yao YG
    Mol Neurobiol; 2016 Jan; 53(1):379-390. PubMed ID: 25452228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.
    Novikova G; Kapoor M; Tcw J; Abud EM; Efthymiou AG; Chen SX; Cheng H; Fullard JF; Bendl J; Liu Y; Roussos P; Björkegren JL; Liu Y; Poon WW; Hao K; Marcora E; Goate AM
    Nat Commun; 2021 Mar; 12(1):1610. PubMed ID: 33712570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation at the CELF1 (CUGBP, elav-like family member 1 gene) locus is genome-wide associated with Alzheimer's disease and obesity.
    Hinney A; Albayrak O; Antel J; Volckmar AL; Sims R; Chapman J; Harold D; Gerrish A; Heid IM; Winkler TW; Scherag A; Wiltfang J; Williams J; Hebebrand J; ; ;
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jun; 165B(4):283-93. PubMed ID: 24788522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor C allele of the SNP rs7873784 associated with rheumatoid arthritis and type-2 diabetes mellitus binds PU.1 and enhances TLR4 expression.
    Korneev KV; Sviriaeva EN; Mitkin NA; Gorbacheva AM; Uvarova AN; Ustiugova AS; Polanovsky OL; Kulakovskiy IV; Afanasyeva MA; Schwartz AM; Kuprash DV
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165626. PubMed ID: 31785408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease.
    Capurso C; Panza F; Seripa D; Frisardi V; Imbimbo BP; Verdile G; Vendemiale G; Pilotto A; Solfrizzi V
    Rejuvenation Res; 2010 Dec; 13(6):645-52. PubMed ID: 20818931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).
    Nowotny P; Simcock X; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Smemo S; Morris JC; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):469-74. PubMed ID: 17427190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
    Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
    J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic dependency of Alzheimer's disease-associated genes across cells and tissue types.
    Jaladanki SK; Elmas A; Malave GS; Huang KL
    Sci Rep; 2021 Jun; 11(1):12107. PubMed ID: 34103633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural study of the microtubule-associated protein tau locus of Alzheimer's disease in Taiwan.
    Chang CW; Hsu WC; Pittman A; Wu YR; Hardy J; Fung HC
    Biomed J; 2014; 37(3):127-32. PubMed ID: 24923570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals.
    Shang Z; Lv H; Zhang M; Duan L; Wang S; Li J; Liu G; Ruijie Z; Jiang Y
    Oncotarget; 2015 Dec; 6(40):42504-14. PubMed ID: 26621834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.